Related Experiment Videos
Pentoxifylline prevents a decrease in arterial oxygen tension in oleic acid-induced lung injury
1Department of Pathopharmacology, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
Critical Care Medicine
|February 1, 1995
Summary
Pentoxifylline administration 40 minutes before oleic acid injection prevented hypoxemia in guinea pigs. This drug may be a potential therapy for lung injuries with similar mechanisms to oleic acid-induced injury.
Area of Science:
- Pulmonary Medicine
- Pharmacology
Background:
- Oleic acid-induced lung injury is a model for acute respiratory distress syndrome (ARDS).
- Hypoxemia and increased pulmonary vascular permeability are key features of this injury model.
Purpose of the Study:
- To evaluate the preventive effect of pentoxifylline on oleic acid-induced hypoxemia.
- To assess pentoxifylline's ability to attenuate pulmonary vascular permeability.
Main Methods:
- Prospective laboratory study using guinea pigs.
- Blood gas analysis (PaO2) and pulmonary vascular permeability measurements were performed.
- Pentoxifylline was administered at various times before or after oleic acid injection.
Main Results:
- Pre-treatment with pentoxifylline (5 or 20 mg/kg) 40 minutes prior to oleic acid significantly prevented the decrease in PaO2.
- Pentoxifylline administered later or after oleic acid did not significantly improve PaO2.
- Pentoxifylline attenuated the increase in pulmonary vascular permeability, similar to theophylline.
Conclusions:
- Pentoxifylline shows promise in preventing hypoxemia associated with lung injury.
- It may be a candidate therapy for conditions sharing mechanisms with oleic acid-induced lung injury.